Welch Group
JAZZ icon

Welch Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Welch Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$209K Hold
903
– – 0.01% 306
2026
Q2 		$218K Buy
+903
New +$198K 0.01% 296

Other funds holding JAZZ

LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Welch Group's JAZZ Position: Q3 2026 in Review

Welch Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 903 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #306.

Welch Group first reported a position in JAZZ in Q2 2026 and has held it in 2 quarters since. The position peaked at $218K in Q2 2026. 331 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Welch Group held 903 shares of Jazz Pharmaceuticals worth $209K as of Q3 2026.
  • Welch Group left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
  • Jazz Pharmaceuticals made up 0.01% of Welch Group's portfolio in Q3 2026, its #306 holding.
  • Welch Group first reported a position in Jazz Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Welch Group's Jazz Pharmaceuticals position peaked at $218K in Q2 2026.
  • 331 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Welch Group's 13F filing for Q3 2026, filed 29 Oct 2026.